A study on the impact of CYP2C19 genotype and platelet reactivity assay on patients undergoing PCI

BACKGROUND: A thorough understanding of the patient's genotype and their functional response to a medication is necessary for improving event free survival. Several outcome studies support this view particularly if the patient is to be started on clopidogrel due to the prevalence of clopidogrel...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Indian Heart J
Päätekijät: Rath, P.C., Chidambaram, Sundar, Rath, Pallavi, Dikshit, Byomakesh, Naik, Sudhir, Sahoo, Prashant K., Das, Brajraj, Mahalingam, Mohanshankar, Khandrika, Lakshmipathi, Jain, Jugnu
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Elsevier 2015
Aiheet:
Original Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4475902/
https://ncbi.nlm.nih.gov/pubmed/26071289
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ihj.2015.03.017
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia